epidiolex sativex epidiolex purified form cannabidiol intended treat seizures tested international clinical trial led university california san francisco epilepsy center granted orphan drug status path approval based smaller clinical studies normal food drug administration sativex mouth spray contains thc cannabidiol approved canada countries not u.s. treatment muscle spasticity multiple sclerosis tested pain treatment maa point pharmaceutical cannabinoid medicines offer consistent potency dosage easier control critical factors cases especially pediatric patients addition conditions studies animals cells published 2014 suggest cannabinoids eventually play helpful role treating kinds disease inducing human breast cancer tumors mice researchers u.k. found shrink tumors administering thc chemical